Egrifta: Followup Regarding Prostate Cancer
Nov 2, 2010
In response to a question posted on 5/23/10, you mentioned asking Serano for input. Did you ever get a response? I was in a clinical trial for tesamorelin a few years ago at St. Luke's in NYC and experienced excellent results. I've recently been diagnosed w/low risk prostate cancer (stage T1c) and have decided, at this time, to choose active surveillance rather than any treatment option. I've been waiting anxiously for FDA approval . . . will be very disappointed if I'm now ineligible. Thanks, SW
Response from Mr. Vergel
Egrifta is a growth hormone releasing hormone that makes your own body produce its own growth hormone. Some clinicians feel uneasy about prescribing growth hormone products to men with prostate cancer since there may be a risk to make the cancer grow, but there is contradictory data about this concern. I guess you can chose to follow your prostate frequently when you start start using it, but you have to ensure that you have a good urologist. Follow your prostatic specific antigen (PSA), digital rectal exam, and possibly ultrasound or biopsy per your urologist recommendations.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.